ExpressPoints:
Advances in Prophylaxis and Treatment of Acute and Chronic GVHD: Expert Guidance and Practical Considerations

Download these expert-selected summary slides on acute and chronic GVHD to help diagnose and manage your patients.
Amin Alousi, MD
Sally Arai, MD
Corey S. Cutler, MD, MPH, FRCPC
Format: Microsoft PowerPoint (.ppt)
File Size: 510 KB
Released: June 28, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Incyte Corporation

Related Content

Download these expert-selected slides on acute and chronic GVHD to help diagnose and manage your patients, from Clinical Care Options (CCO).

Amin Alousi, MD Sally Arai, MD Corey S. Cutler, MD, MPH, FRCPC Released: June 23, 2021

Dr. Corey S. Cutler shares his views on current and future graft-vs-host disease (GVHD) therapies in this commentary from Clinical Care Options (CCO)

Corey S. Cutler, MD, MPH, FRCPC Released: April 27, 2021

Steven Waguespack, MD, on hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and the mechanism of hyperthyroidism in cancer survivors from Clinical Care Options (CCO)

Steven G. Waguespack, MD Released: April 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue